Two Virginia projects — one to make Central Virginia an advanced pharmaceutical manufacturing hub and one to support the transportation and logistics cluster in Southern and Southwest Virginia — are two of 60 finalists for the U.S. Economic Development Administration’s Build Back Better Regional Challenge, which will provide awardees with up to $100 million each.
Pharmaceutical manufacturer plans to invest $25 million
AMPAC Fine Chemicals plans to grow its Petersburg manufacturing facility, investing $25 million and creating 156 jobs, Gov. Ralph Northam announced Tuesday. AMPAC manufactures active pharmaceutical ingredients (APIs) and is a partner with Richmond-based Phlow Corp., Virginia Commonwealth University’s Medicines for All Institute and nonprofit drugmaker Civica Inc., on a federally funded, $354 million contract
VCU announces strategy to drive business and job growth in region
On Tuesday, the Virginia Commonwealth University College of Engineering announced its strategy to turn Central Virginia into an advanced pharmaceutical manufacturing, research and development hub. The strategic plan aims to foster business and job growth in the Richmond-Petersburg area while also expanding access to medicines. The creation of the plan was funded by a $100,000
Collaboration to address pediatric drug shortages
Richmond-based Phlow Corp. announced Thursday the launch of a coalition that will help ensure that children’s hospitals across the country receive key medications. The Virginia Commonwealth University-affiliated Children’s Hospital of Richmond is one of 11 founding hospital members. Children’s Hospital Coalition (CHC) aims to provide certainty in availability and access to medicine and address supply
Civica will manufacture COVID-19 medicines, partnering with Richmond's Phlow Corp.
Utah-based pharmaceutical manufacturer Civica Inc. plans to invest $124.5 million to establish its North American manufacturing headquarters operation in Petersburg, creating 186 jobs and manufacturing injectable medicines for the treatment of COVID-19, the governor’s office announced Thursday. A nonprofit generic drug company, Civica was established in 2018 by a group of U.S. health systems and
Phlow Corp. will create domestic supply chain for coronavirus drugs
Richmond-based drug manufacturing company Phlow Corp., which incorporated this year, announced Tuesday that the Trump administration has awarded it a $354 million, four-year contract to manufacture in the U.S. generic medicines and pharmaceutical ingredients needed to treat COVID-19, creating an American supply chain for medical products that are now made mostly in China and India.